New microRNA test could spare thousands from unnecessary thyroid surgery
NCT ID NCT04285476
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new way to analyze thyroid nodules that look suspicious but not clearly cancerous. Researchers are checking if a set of microRNA molecules can better predict which nodules are actually cancer. The goal is to help patients avoid unnecessary surgery. The study involves 71 adults with thyroid nodules that need further testing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Nîmes
Nîmes, 30029, France
-
CHU de Toulouse
Toulouse, Haute-Garonne, 31000, France
-
Institut régional du Cancer de Montpellier
Montpellier, Hérault, 34298, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple tool may help thyroid cancer patients avoid treatment regret
- Drug duo aims to starve thyroid tumors
- Could your DNA predict thyroid cancer after radiation?
- Smartphone app could ease neck pain after thyroid surgery
- New imaging tracer could spot hidden cancers and fibrosis in one scan
- Cancer drug pralsetinib may change how the body processes other medications